Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prostate epithelial stem cells.

S Rizzo1, G Attard, D L Hudson

  • 1The Bob Champion Prostate Stem Cell Laboratory, Institute of Cancer Research, 15 Cotswold Road, Sutton, Surrey, UK, SM2 5NG.

Cell Proliferation
|November 23, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multimodal Artificial Intelligence Prediction of Abiraterone Efficacy in Two STAMPEDE Phase 3 Trials of Non-Metastatic Very High-Risk Prostate Cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2026
Same author

Eosinophilic myocarditis: diagnostic pitfalls and therapeutic challenges. A Case Series.

Frontiers in cardiovascular medicine·2026
Same author

Monoclonal antibodies targeting IL-5/5R or IL-4/13 pathways in eosinophilic myocarditis: a single-center experience and systematic literature review.

European heart journal. Cardiovascular pharmacotherapy·2026
Same author

Advanced and metastatic prostate cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.

Annals of oncology : official journal of the European Society for Medical Oncology·2026
Same author

Local and locoregional prostate cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

Fracture-related hospitalisations in newly diagnosed high-risk localised or metastatic hormone-sensitive prostate cancer: secondary analysis of the STAMPEDE phase III trials of docetaxel and zoledronic acid using healthcare systems data.

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same journal

PLIN5 Protects Against Ang II-Induced Podocyte Lipotoxicity by Interacting With FKBP8 and Preserving Lipid Droplet-Mitochondria Contact.

Cell proliferation·2026
Same journal

Unveiling Gut Homeostasis Disruption in Sepsis: Towards an Integrated Mechanistic and Translational Roadmap.

Cell proliferation·2026
Same journal

The E-cadherin-Wnt-mir-994 Axis Repurposes a Cadherin Switch for Niche Robustness and Germline Stem Cell Maintenance.

Cell proliferation·2026
Same journal

A Multicellular Coordinated Network Driving Lymphovascular Space Invasion in Endometrioid Endometrial Carcinoma.

Cell proliferation·2026
Same journal

RETRACTION: Long Non-Coding RNA HCG11 Modulates Glioma Progression Through Cooperating With miR-496/CPEB3 Axis.

Cell proliferation·2026
Same journal

Lactate-Primed NETosis Modulates Hepatic Regeneration During Acute Liver Failure via the TLR9/KLF15/AJUBA Axis.

Cell proliferation·2026
See all related articles

Prostate cancer may originate from stem cells expressing CD133 but lacking androgen receptors. Research explores the evidence and maintenance of these prostate cancer stem cells.

Area of Science:

  • Oncology
  • Cell Biology
  • Urology

Background:

  • Prostate cancer is a leading cancer diagnosis in men.
  • Cancer development is often linked to stem cells.
  • Normal prostate stem cells exhibit basal cell phenotype and CD133 expression.

Purpose of the Study:

  • To review evidence for prostate cancer stem cells.
  • To discuss mechanisms of prostate cancer stem cell maintenance.
  • To investigate CD133 expression in prostate cancer stem cells.

Main Methods:

  • Literature review of existing studies.
  • Analysis of preliminary data on prostate cancer stem cells.
  • Examination of cell surface marker expression (CD133, androgen receptor).

Related Experiment Videos

Main Results:

  • Prostate cancer stem cells may express CD133.
  • These cancer stem cells appear to lack androgen receptor expression.
  • Evidence supports the existence of a distinct prostate cancer stem cell population.

Conclusions:

  • Prostate cancer stem cells represent a potential origin for the disease.
  • Understanding these cells is crucial for developing targeted therapies.
  • Further research is needed to elucidate stem cell maintenance pathways.